Macular Hole Reopening

Status Completed

Clinical Trial Summary

The purpose of this investigation was to determine the incidence and the factors that cause a reopening of a macular hole (MH) after a surgical closure.

Clinical Trial Description

A reopening of a macular hole (MH) is a well-known complication of successfully closed MHs. Recently, internal limiting membrane (ILM) peeling has become widely used as an adjunctive procedure during MH surgery. The incidence of a reopening of a MH is 0 to 8.6% in eyes in which the ILM was peeled off, and 2 to 16% in which the ILM was not peeled off. Part of the variation in the percentages of reopening was the length of the follow-up period; eyes with longer follow-up periods have higher incidences of reopening. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Vitrectomy

Clinical Trial Details

NCT number	NCT00927628
Study type	Observational
Source	Shinjo Ophthalmologic Institute
Contact
Status	Completed
Phase	N/A
Start date	October 1990
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT04409808` - IRIS Alfa Clinical Trial A Monocentric, Academic Clinical Trial Safety Study of a Prototype of a New Vitrectomy Device.	N/A
Active, not recruiting	`NCT04566237` - Objective Measurements of the Opacification of the Lens After Vitrectomy	N/A
Completed	`NCT00532415` - Safety and Efficacy of Vitreous Delineating Agent During Vitrectomy	Phase 3
Completed	`NCT04076072` - Beveled-Tip Versus(vs) Standard-Tip Vitrectomy Probe	N/A
Not yet recruiting	`NCT03633266` - Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy	N/A
Not yet recruiting	`NCT03637283` - Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage	N/A
Completed	`NCT01255293` - Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments	N/A
Terminated	`NCT01023009` - Postoperative Evolution After Small Gauge Vitrectomy Without Eye Occlusion
Completed	`NCT00737022` - Macular Appearance After Diabetic Vitrectomy	N/A
Completed	`NCT03902795` - Functional and Morphological Results of Rhegmatogenous Retinal Detachment Treated With Vitrectomy
Completed	`NCT02644694` - PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy	Phase 1
Completed	`NCT01319318` - Observational Study of Ocular Inflammation in Patients Undergoing a Pars Plana Vitrectomy	N/A
Not yet recruiting	`NCT04346095` - Oral Sedation in Vitreoretinal Surgery	Phase 4
Completed	`NCT01159665` - The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)	Phase 2
Completed	`NCT00685490` - Vitrectomy for Branch Retinal Vein Occlusion	N/A
Completed	`NCT05446948` - Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy	N/A
Completed	`NCT05710458` - Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter	N/A
Terminated	`NCT02995746` - Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane	N/A
Completed	`NCT03701542` - The Application of M-charts and Microperimetry for the Assessment of Visual Function in Patients After Vitrectomy Due to the Full Thickness Macular Hole.
Completed	`NCT00799227` - Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema	Phase 2